Immix Biopharma IMMX
NASDAQ IMMX
$8.66 +0.31 (+3.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Immix Biopharma (IMMX) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

Immix Biopharma (IMMX) posted Return on Capital Employed [ROCE] of -26.44% for Q2 2026, up 280.28 percentage points from -306.72% a year earlier and up 13.74 percentage points from the prior quarter.

Analysis

Immix Biopharma (IMMX) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, Immix Biopharma's Return on Capital Employed [ROCE] came in at -55.70%, up 122.15 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -40.94 percentage points (FY2021 to FY2025).
  • In prior years, Immix Biopharma's Return on Capital Employed [ROCE] was -177.85% in FY2024 (-59.99 pp), -117.86% in FY2023 (-64.06 pp), -53.80% in FY2022 (-39.05 pp) and -14.75% in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q2 2022.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last three quarters, with an average year-over-year change of -15.31 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 280.28 percentage points; the weakest was Q2 2025, with a drop of 233.80 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -40.18% (Q1 2026), -57.22% (Q4 2025) and -343.22% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Immix Biopharma 597.32 Mn 365.22 Mn - -26.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.44%
Mar 31, 2026 -40.18%
Dec 31, 2025 -57.22%
Sep 30, 2025 -343.22%
Jun 30, 2025 -306.72%
Mar 31, 2025 -179.71%
Dec 31, 2024 -147.64%
Sep 30, 2024 -112.92%
Jun 30, 2024 -72.92%
Mar 31, 2024 -89.44%
Dec 31, 2023 -92.35%
Sep 30, 2023 -89.90%
Jun 30, 2023 -96.47%
Mar 31, 2023 -74.76%
Dec 31, 2022 -55.24%
Sep 30, 2022 -28.55%
Jun 30, 2022 -20.66%
Mar 31, 2022 -13.44%
API Access

Immix Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMMX&period=max&api_key=YOUR_API_KEY